Skip to main content

Table 1 Clinical characteristics of study subjects

From: DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A binding

Characteristic

Cases (n = 15)

Controls (n = 17)

P value

Age (years)

39.33 ± 5.94

36.12 ± 7.66

0.12

Male (n)

15

17

1

Serum uric acid (μmol/L)

535.80 ± 38.31

320.65 ± 66.80

1.42E−11

Creatinine (μmol/L)

68.80 ± 28.18

56.94 ± 12.00

0.21

Body mass index (kg/m2)

24.81 ± 3.64

22.16 ± 3.52

0.04

Cholesterol (mg/dL)

197.20 ± 99.09

134.24 ± 49.02

0.03

Triglycerides (mg/dL)

149.73 ± 33.21

120.29 ± 43.33

0.04

Cancer (n)

0

0

1

Smoker (n)

0

0

1

  1. Values are mean ± SD or numbers. P value for the difference between cases and controls